Survivin, Ki-67, cyclin D, phosphorylated-Rb, underphosphorylated-Rb, and % S + G2/M cells in Tpo-, SCF-, and FL-stimulated CD34+ cells
Cell population . | No. of experiments . | Fold increase . | |||
---|---|---|---|---|---|
2 hours after growth factor addition* . | 4 hours after growth factor addition* . | 6 hours after growth factor addition* . | 18 hours after growth factor addition* . | ||
Survivin protein | 4 | 1.4 ± 0.2 | 1.8 ± 0.2‡ | 2.4 ± 0.5† | 6.2 ± 2.4† |
Survivin mRNA | 3 | 1.1 ± 0.1 | 1.2 ± 0.1† | 2.1 ± 0.5† | 10.3 ± 3.8† |
%S + G2M phase | 4 | 7.5 ± 1.2 | 6.9 ± 1.0 | 8.5 ± 1.2† | 19.9 ± 3.1† |
Ki-67 | 2 | 1.3 ± 0.011-153 | 1.3 ± 0.021-153 | 1.2 ± 0.011-153 | 1.5 ± 0.21-153 |
Cyclin D | 5 | 1.1 ± 0.1† | 1.2 ± 0.1† | 1.2 ± 0.1‡ | 1.5 ± 0.2† |
Phosphorylated Rb/Total Rb | 2 | 1.7 ± 0.6† | 1.5 ± 0.5† | 1.8 ± 0.7† | 2.3 ± 0.6† |
Underphosphorylated Rb/Total Rb | 3 | 0.8 ± 0.1† | 0.7 ± 0.1‡ | 0.7 ± 0.1† | 0.5 ± 0.11-153 |
Cell population . | No. of experiments . | Fold increase . | |||
---|---|---|---|---|---|
2 hours after growth factor addition* . | 4 hours after growth factor addition* . | 6 hours after growth factor addition* . | 18 hours after growth factor addition* . | ||
Survivin protein | 4 | 1.4 ± 0.2 | 1.8 ± 0.2‡ | 2.4 ± 0.5† | 6.2 ± 2.4† |
Survivin mRNA | 3 | 1.1 ± 0.1 | 1.2 ± 0.1† | 2.1 ± 0.5† | 10.3 ± 3.8† |
%S + G2M phase | 4 | 7.5 ± 1.2 | 6.9 ± 1.0 | 8.5 ± 1.2† | 19.9 ± 3.1† |
Ki-67 | 2 | 1.3 ± 0.011-153 | 1.3 ± 0.021-153 | 1.2 ± 0.011-153 | 1.5 ± 0.21-153 |
Cyclin D | 5 | 1.1 ± 0.1† | 1.2 ± 0.1† | 1.2 ± 0.1‡ | 1.5 ± 0.2† |
Phosphorylated Rb/Total Rb | 2 | 1.7 ± 0.6† | 1.5 ± 0.5† | 1.8 ± 0.7† | 2.3 ± 0.6† |
Underphosphorylated Rb/Total Rb | 3 | 0.8 ± 0.1† | 0.7 ± 0.1‡ | 0.7 ± 0.1† | 0.5 ± 0.11-153 |
Survivin, cyclin D, Ki-67, phosphorylated-Rb (Ser 807/811), underphosphorylated-Rb, and total-Rb protein levels were determined by intracellular flow cytometry in the CD34+ cell population from UCB. The fold increases in mean channel fluorescence for each protein and the ratio of fold changes of phosphorylated Rb/total Rb and underphosphorylated Rb/total Rb are shown as means ± SEM of the number of experiments indicated. Survivin mRNA was determined by real-time RT-PCR. The percentage of CD34+ cells in S + G2/M phase was measured by DNA staining with 7-AAD and analyzed using ModFit software. Data are presented as means ± SEM of 4 experiments.
100 ng/mL each rhTpo, rhFL, rhSCF.
P < .05.
P < .01.
P < .005 compared with time 0.